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A
lthough efficacious in vitro, it is 
well known that adoptive immuno-
therapeutic modalities lose their potency 
when applied in vivo. Furthermore, 
malignant cell exposure to blood plate-
lets attenuates the anticancer activity of 
natural killer (NK) cells. We argue that 
upon contact with redox iron, fibrinogen 
is converted to a hydrophobic fibrin-like 
polymer that coats tumor cells and pro-
vides protection from immune-mediated 
destruction.
Introduction
Placke et al.1 have recently presented 
a view that blood platelets impair natu-
ral killer (NK) cells ability to recognize 
cancer cells by forming a physical barrier 
around the tumor cells. In connection 
with this it should be remembered that 
platelet require for their proper functions 
the presence of fibrinogen, an essential 
component of blood coagulation cascade.2 
Fibrinogen (FBG) is a large molecular 
weight (340 kDa) multi-chain plasma 
protein that is converted with thrombin 
to fibrin monomer(s) (FM), an essential 
component of the clotting assembly that 
spontaneously polymerizes to form fibrin 
clots. However, prior to the formation of 
solid clots FMs remain soluble by forming 
complexes with the intact fibrinogen mol-
ecules. Due to the increased hydrophobic-
ity of fibrin monomers3 such complexes 
readily interact with cellular membranes 
of cells in the blood system. Thus, in 
addition to inducing platelet aggrega-
tion, FM complexes have been shown to 
cause red blood cell (RBC) agglutina-
tion and increased sedimentation,4 as 
well as cell aggregation of the bacterium 
Staphylococci.5 Under normal hemostatic 
conditions fibrin clots are susceptible to 
degradation by the blood fibrinolytic sys-
tem that secures proper wound healing 
and growth of connective tissue at the site 
of vessel wall injury. This system is acti-
vated by the release of tissue plasminogen 
activator (tPA) resulting in the genera-
tion of active plasmin that under normal 
conditions effectively degrades fibrin 
into soluble fragments. However, it is not 
understood why degradation of fibrin 
in certain types of cancer is incomplete, 
despite increased tPA production as in the 
case of prostate cancer.6
Mechanism of Parafibrin 
Formation
We have previously reported that the 
exposure of plasma proteins to disulfide-
reducing agents resulted in the formation 
of huge insoluble aggregates, which when 
adhered to tumor cell membranes have 
been proposed to act as a barrier to tumor 
recognition by the innate immune system.7 
Subsequently, it was further documented 
that similar aggregates could be induced 
with another non-enzymatic agent, free 
iron ions.8 In contrast to thrombin-gener-
ated fibers, those formed in the presence 
of iron ions exhibit dramatically different 
physicochemical properties. The first step 
in this conversion involves the interaction of 
trivalent iron ions (Fe3+) with the hydroxyl 
groups of water to form highly reactive 
hydroxyl radicals (HO.) according to the 
following reaction: HO + Fe3+ → HO. + Fe2+
Of note, our first observance of this 
reaction took place without the involve-
ment of hydrogen peroxide required for 
the classic Fenton reaction. The hydroxyl 
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radicals generated by the interaction of 
hydroxyl and iron cleaves intra-molec-
ular disulfide bonds in the fibrinogen 
molecules causing their unfolding with 
the exposure of hydrophobic groups 
normally buried inside the tridimen-
sional structure of the polypeptide 
chains. In the absence of specific chap-
erons the exposed hydrophobic epitopes 
form scrambled intermolecular linkages 
resulting in the formation of fibrin-like 
fibrils (parafibrin). The most important 
feature of parafibrin is its hydrophobic-
ity and total resistance to proteolytic 
degradation. This unusual phenomenon 
is due to the fact that the hydrophobic 
forces holding together the polypeptide 
chains are purely physical and do not 
involve peptide bonds.9 Consequently, 
once attached to the surfaces of various 
cells, parafibrin induces a permanent 
state of inflammation by eliciting the 
release of cytokines and proteases from 
macrophages that impairs their normal 
functions.
The damaging effect of parafibrin has 
recently been extended to the pathogen-
esis of cardiovascular10 and Alzheimer 
disease.11 These pathological conditions 
share a common mechanism by which 
native FBG molecules become hydro-
phobic by a single event of the conver-
sion from the folded to the unfolded 
state. This phenomenon is very similar 
to that occurring when native prion pro-
tein PrP becomes converted to its toxic 
form PrPSc simply by unfolding, without 
any alteration in its primary structure.12 
Interestingly enough, this concept has 
been met for many years with great skep-
ticism from mainstream protein scien-
tists, until its author was awarded with a 
Nobel Prize.
Iron and Cancer
Accumulating evidence suggests that 
a correlation exists between increased 
blood concentration of unbound iron and 
the incidence of cancer in humans.13,14 
Furthermore, iron level reduction may 
prevent cancer morbidity and mortal-
ity.15-17 It should be noted that it is only 
trivalent iron (Fe3+) and not divalent 
(Fe2+) which participate in the generation 
of hydroxyl radicals and subsequent for-
mation of insoluble parafibrin from sol-
uble plasma fibrinogen.8 However, when 
hemoglobin is released from the hemo-
lyzed erythrocytes, the divalent ferrous 
ions are enzymatically converted to ferric 
ions. Thus, any pathologic condition in 
which erythrocyte membranes are dam-
aged, e.g., in response to infections and/
or exposure to environmental toxins, may 
contribute to the excessive body storage 
of trivalent iron. It should be noted that 
this form of iron accumulates with age 
due to the fact that there is no mecha-
nism for its physiologic elimination, and 
may therefore underlie prior observations 
of associations between cancer incidence 
and aging.
Figure 1. Conceptual scenarios of the interaction between natural killer cells and cancer cells. 
natural killer (nK) cells attack those tumor cells that appear to as “non-self,” but spare the “self” 
identified cancer cells, including those coated with “self” parafibrin polypetide chains.
Figure 2. Displacement of parafibrin protective coat from the cancer cell membrane by an amphi-
philic substance. the hydrophobic groups of the amphiphilate form strong complexes with those 
of cancer cell membrane, thus diplacing the polypeptide backbone of parafibrin thereby increas-
ing its water solubility due to hydrophilic group enrichment.©
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Current Issues of Cancer 
Immunotherapies
It is of extreme importance to remem-
ber that the presence of fibrin-like 
deposits, identified as thrombosis, has 
been reported for almost a century.18-20 
However, no explanations have been 
offered why such deposits are not being 
removed by the fibrinolytic enzymes fre-
quently found to be dramatically acti-
vated in tumors, particularly in prostate 
cancer.6 Apparently, there must be some 
post-translational modifications of fibrin-
ogen/fibrin structure that render the 
tumor  thrombi resistant the proteolytic 
degradation. The same phenomenon may 
also be responsible for the disappoint-
ing results of chemotherapy for the most 
types of solid tumors. In the past decade, 
attempts have being made to develop 
alternative methods using adaptive and/
or adoptive immunotherapies.21 It is of 
interest to note that while some the adop-
tive modalities work perfectly well in 
artificially contrived systems in vitro they 
lose their efficacies in the physiologically 
relevant environment in vivo. Obviously 
the difference is in the exposure of tumor 
and immune cells to blood and its com-
ponents as emphasized by Placke et al.1 
As mentioned before another important 
hemostatic factor is plasma fibrinogen 
that, in the presence of free iron, is con-
verted to parafibrin. We propose that this 
insoluble polymer forms a protective bar-
rier around tumor cells by means of the 
hydrophobic interaction, similar to those 
operating in the phenomena of erythro-
cyte and bacterial cells aggregations. The 
role of parafibrin in tumor immune eva-
sion can be compared with that ascribed 
to the desmoplastic stroma in pancreatic 
cancer.21  It should be born in mind, how-
ever, that even the most active NK cells 
generated ex vivo cannot degrade this bar-
rier because hydrophobic forces holding it 
together do not represent a substrate for 
the action of proteolytic enzymes.9
The dual role of parafibrin in the 
tumor evasion is graphically presented 
in Figure 1. First, because the antigenic 
properties of this polymer are almost iden-
tical to plasma fibrinogen and/or fibrin, 
parafibrin is seen by the innate immune 
system as “self.” Second, and more impor-
tantly, even if parafibrin attracts immune 
cells, it cannot be removed due to its 
remarkable resistance to degradative pro-
teases normally liberated from activated 
NK cells.22
The Role of Polyphenols and 
Other Dietary Agents
In view of the known cancer protec-
tive effect of Mediterranean diet23,24 it is 
quite possible that certain polyphenolic 
substances present in this diet, such as 
EGCG,25 ferulic acid,26 and curcumin27 
may exert their preventive and/or thera-
peutic effects by helping remove the pro-
tective barrier from the tumor membranes. 
The proposed mechanism of the action of 
polyphenols is based on their amphiphi-
lic character that allows parafibrin to be 
displaced in a zipper-like manner (Fig. 2).
This mechanism is similar to that 
operating in the removal of fat by deter-
gents, in which the hydrophobic groups 
of a detergent react with the non-polar 
regions of the fat with the exposure of 
hydrophilic sites to the aqueous milieu. In 
addition to these organic substances sug-
gested here to displace parafibrin from the 
tumor cell surfaces, there are two miner-
als that may also play an important role in 
this phenomenon. Thus, magnesium ions 
contained in green leaves and vegetables 
may exert their anticancer properties28 by 
inhibiting the intrinsic blood coagulation 
and in this way limiting the formation of 
parafibrin as indicated in the pathogenesis 
of Alzheimer disease11 The other essential, 
albeit not generally recognized mineral, is 
selenium that in a specific chemical form 
as sodium selenite blocks the protein thiol 
groups and subsequently inhibit protein 
unfolding and scrambled refolding.29 
Finally, it should be emphasized that the 
present concept of parafibrin formation 
and its role in tumor evasion would not be 
possible without the pioneering work on 
the protein structure-function relation-
ship elucidated by the great American pro-
tein chemist, Chris Anfinsen.30
Conclusions
Our perspective is that a singular elec-
tron transfer event from the redox iron ion 
into the hydroxyl group of water can initi-
ate a chain of events that can explain the 
enigmatic phenomenon of immune eva-
sion. This novel concept offers an addi-
tional scenario accounting for improper 
tumor immunoediting, as well as foster-
ing a defective cellular immune system. 
However, a philosophical question arises 
whether such a simple idea can find its 
place in this day-and-age of the enormous 
complexity and technical sophistication of 
the current cancer research.
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